Cataract surgery significantly improves both distance and near vision in patients with neovascular age-related macular degeneration undergoing anti-vascular endothelial growth factor treatment ...

In this CE activity, Drs. Christina Weng and Nathan Steinle discuss individualized management options for a community-based nAMD patient case, offering insights into best practices for durable ...

This program equips comprehensive ophthalmologists with the latest data on current and emerging therapies for nAMD, DME, and DR that promise to reduce treatment burden.

A single injection of ixoberogene soroparvovec reduced anti-VEGF injection needs by 90%-95% at 26 weeks in patients with neovascular age-related macular degeneration.

New treatments for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) enhance patient care with gene therapies and new mechanisms of action on the horizon ...

Exegenesis Bio Announces FDA Clearance of Investigational New Drug (IND) Application for EXG102-031; A Novel Gene Therapy for the Treatment of neovascular Age-Related Macular Degeneration (nAMD) ...